Updated Austrian treatment algorithm in HER2+ metastatic breast cancer

A group of Austrian breast cancer specialists met in December 2020 to establish a comprehensive clinical benefit-risk profile of available HER2-targeted therapies based on recent data and to develop an updated treatment algorithm by consensus over several months in 2021. A total of four scenarios we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartsch, Rupert, Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Petru, Edgar, Egle, Daniel, Petzer, Andreas, Balic, Marija, Pluschnig, Ursula, Sliwa, Thamer, Singer, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Consensus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813714/
https://www.ncbi.nlm.nih.gov/pubmed/35089396
http://dx.doi.org/10.1007/s00508-021-01987-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813714/
https://www.ncbi.nlm.nih.gov/pubmed/35089396
http://dx.doi.org/10.1007/s00508-021-01987-9

Ejemplares similares